PLA2G4A and non-small cell lung carcinoma: Inhibition of prostaglandin production via blocking either cPLA2 or COX-2 inhibits transformed growth of non-small cell lung cancer cells (NSCLC), and the development of tumors in mice in response to chemical carcinogens [9].